Document is current
Any future updates will be listed below
-
Authors
Cromer, M. Kyle https://orcid.org/0000-0002-8198-5010
Camarena, Joab https://orcid.org/0000-0002-3102-5820
Martin, Renata M. https://orcid.org/0000-0003-2996-4260
Lesch, Benjamin J.
Vakulskas, Christopher A. https://orcid.org/0000-0001-8510-4332
Bode, Nicole M. https://orcid.org/0000-0001-7209-303X
Kurgan, Gavin https://orcid.org/0000-0002-4047-1427
Collingwood, Michael A. https://orcid.org/0000-0002-8849-4038
Rettig, Garrett R. https://orcid.org/0000-0003-4634-5787
Behlke, Mark A. https://orcid.org/0000-0002-4218-857X
Lemgart, Viktor T.
Zhang, Yankai
Goyal, Ankush
Zhao, Feifei
Ponce, Ezequiel
Srifa, Waracharee https://orcid.org/0000-0002-6821-2451
Bak, Rasmus O. https://orcid.org/0000-0002-7383-0297
Uchida, Naoya https://orcid.org/0000-0001-6322-8991
Majeti, Ravindra https://orcid.org/0000-0002-5814-0984
Sheehan, Vivien A.
Tisdale, John F.
Dever, Daniel P. https://orcid.org/0000-0001-5966-4803
Porteus, Matthew H. https://orcid.org/0000-0002-3850-4648
-
Funding
Funding for this research was provided by:
Doris Duke Charitable Foundation (22399)
- License Information
-
More Information
Article History
Received: 8 October 2019
Accepted: 9 February 2021
First Online: 18 March 2021
Competing interests
: M.H.P. is a member of the scientific advisory board of Allogene Therapeutics. M.H.P. is on the Board of Directors of Graphite Bio. M.H.P. has equity in CRISPR Tx. C.A.V., N.M.B., G.K., M.A.C., G.R.R. and M.A.B. are employees of Integrated DNA Technologies. D.P.D. is an employee of Graphite Bio.
